SCHEMBL8273636

SCHEMBL8273636

Cc1nnc([C@H](O)[C@@H](O)C(=O)NCC2CCN(c3ccc(F)cc3N)CC2)n1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ RPS6KB1 P23443 2/20 0.36
▸ HTT P42858 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ HDAC3 O15379 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HPGD P15428 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CKS1B P61024 1/20 0.34
▸ SKP1 P63208 1/20 0.34
▸ SKP2 Q13309 1/20 0.34
▸ PDE6D O43924 1/20 0.34
▸ HRAS P01112 1/20 0.34
▸ KRAS P01116 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273638 0.89 ALDH1A1 (0.38) ALDH1A1L3MBTL1RPS6KB1HTTGAA
SCHEMBL8222096 0.88 CHRM4 (0.43) RPS6KB1ADAM17USP30
SCHEMBL8273640 0.86 ALDH1A1 (0.38) ALDH1A1L3MBTL1RPS6KB1HTTGAA
SCHEMBL8273643 0.85 ALDH1A1 (0.38) ALDH1A1L3MBTL1RPS6KB1HTTGAA
SCHEMBL8273633 0.84 CKS1B (0.41) ALDH1A1L3MBTL1RPS6KB1KDM4EHPGD
SCHEMBL8275481 0.83 PIK3CB (0.43) ALDH1A1L3MBTL1HTTGAAKDM4E
SCHEMBL8273635 0.82 CKS1B (0.37) ALDH1A1L3MBTL1RPS6KB1KDM4EHPGD
SCHEMBL8276134 0.81 ADAM17 (0.37) ALDH1A1L3MBTL1RPS6KB1HTTGAA
SCHEMBL8275485 0.80 CKS1B (0.39) ALDH1A1L3MBTL1KDM4EHPGDRAB9A
SCHEMBL8275791 0.80 KDM4E (0.34) ALDH1A1GAAKDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback